Penn Capital Management Company LLC Acquires New Position in U.S. Physical Therapy, Inc. $USPH

Penn Capital Management Company LLC bought a new position in U.S. Physical Therapy, Inc. (NYSE:USPH) in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 9,431 shares of the company’s stock, valued at approximately $648,000. Penn Capital Management Company LLC owned approximately 0.06% of U.S. Physical Therapy at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Hantz Financial Services Inc. lifted its holdings in U.S. Physical Therapy by 56.4% during the fourth quarter. Hantz Financial Services Inc. now owns 366 shares of the company’s stock valued at $29,000 after purchasing an additional 132 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new stake in shares of U.S. Physical Therapy in the second quarter worth $30,000. Advisory Services Network LLC purchased a new stake in shares of U.S. Physical Therapy in the third quarter worth $39,000. iSAM Funds UK Ltd bought a new stake in shares of U.S. Physical Therapy during the 3rd quarter valued at $52,000. Finally, Parallel Advisors LLC raised its position in shares of U.S. Physical Therapy by 75.2% during the 1st quarter. Parallel Advisors LLC now owns 785 shares of the company’s stock valued at $59,000 after purchasing an additional 337 shares during the period.

Insider Buying and Selling at U.S. Physical Therapy

In other U.S. Physical Therapy news, Director Peter Francis Minan bought 492 shares of the business’s stock in a transaction that occurred on Monday, June 8th. The stock was purchased at an average cost of $63.14 per share, with a total value of $31,064.88. Following the completion of the acquisition, the director owned 2,923 shares in the company, valued at $184,558.22. This trade represents a 20.24% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 2.40% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on USPH shares. Citizens Jmp reaffirmed a “market outperform” rating and issued a $98.00 target price on shares of U.S. Physical Therapy in a report on Wednesday, June 24th. Zacks Research upgraded U.S. Physical Therapy from a “strong sell” rating to a “hold” rating in a research report on Wednesday, May 27th. Barrington Research upped their price objective on U.S. Physical Therapy from $90.00 to $98.00 and gave the stock an “outperform” rating in a research note on Monday, August 10th. Citigroup reiterated a “market outperform” rating on shares of U.S. Physical Therapy in a research report on Wednesday, August 19th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of U.S. Physical Therapy in a research note on Wednesday. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $99.50.

U.S. Physical Therapy Trading Down 0.6%

Shares of USPH stock opened at $78.61 on Friday. U.S. Physical Therapy, Inc. has a 12-month low of $58.19 and a 12-month high of $93.50. The company has a current ratio of 1.27, a quick ratio of 1.27 and a debt-to-equity ratio of 0.48. The stock’s 50-day moving average price is $74.97 and its 200-day moving average price is $73.71. The stock has a market capitalization of $1.17 billion, a price-to-earnings ratio of 462.44, a price-to-earnings-growth ratio of 2.16 and a beta of 1.13.

U.S. Physical Therapy (NYSE:USPH) last announced its quarterly earnings results on Thursday, August 6th. The company reported $0.75 EPS for the quarter, missing analysts’ consensus estimates of $0.81 by ($0.06). The firm had revenue of $214.06 million for the quarter, compared to the consensus estimate of $211.36 million. U.S. Physical Therapy had a net margin of 3.97% and a return on equity of 9.39%. U.S. Physical Therapy’s quarterly revenue was up 8.5% on a year-over-year basis. During the same period in the previous year, the company posted $0.81 earnings per share. Equities research analysts predict that U.S. Physical Therapy, Inc. will post 2.95 EPS for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, September 11th. Stockholders of record on Friday, August 21st will be given a dividend of $0.46 per share. This represents a $1.84 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date is Friday, August 21st. U.S. Physical Therapy’s dividend payout ratio is currently 1,082.35%.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.